364 related articles for article (PubMed ID: 32185886)
21. Incorporating historical controls in clinical trials with longitudinal outcomes using the modified power prior.
Qi H; Rizopoulos D; Lesaffre E; van Rosmalen J
Pharm Stat; 2022 Sep; 21(5):818-834. PubMed ID: 35128780
[TBL] [Abstract][Full Text] [Related]
22. A group-sequential randomized trial design utilizing supplemental trial data.
Kotalik A; Vock DM; Hobbs BP; Koopmeiners JS
Stat Med; 2022 Feb; 41(4):698-718. PubMed ID: 34755388
[TBL] [Abstract][Full Text] [Related]
23. Elastic priors to dynamically borrow information from historical data in clinical trials.
Jiang L; Nie L; Yuan Y
Biometrics; 2023 Mar; 79(1):49-60. PubMed ID: 34437714
[TBL] [Abstract][Full Text] [Related]
24. An efficient Bayesian platform trial design for borrowing adaptively from historical control data in lymphoma.
Normington J; Zhu J; Mattiello F; Sarkar S; Carlin B
Contemp Clin Trials; 2020 Feb; 89():105890. PubMed ID: 31740427
[TBL] [Abstract][Full Text] [Related]
25. Optimizing interim analysis timing for Bayesian adaptive commensurate designs.
Wu X; Xu Y; Carlin BP
Stat Med; 2020 Feb; 39(4):424-437. PubMed ID: 31799737
[TBL] [Abstract][Full Text] [Related]
26. Robust incorporation of historical information with known type I error rate inflation.
Calderazzo S; Wiesenfarth M; Kopp-Schneider A
Biom J; 2024 Jan; 66(1):e2200322. PubMed ID: 38063813
[TBL] [Abstract][Full Text] [Related]
27. Bayesian sample size determination in basket trials borrowing information between subsets.
Zheng H; Grayling MJ; Mozgunov P; Jaki T; Wason JMS
Biostatistics; 2023 Oct; 24(4):1000-1016. PubMed ID: 35993875
[TBL] [Abstract][Full Text] [Related]
28. A Bayesian basket trial design using a calibrated Bayesian hierarchical model.
Chu Y; Yuan Y
Clin Trials; 2018 Apr; 15(2):149-158. PubMed ID: 29499621
[TBL] [Abstract][Full Text] [Related]
29. Bayesian adaptive design for pediatric clinical trials incorporating a community of prior beliefs.
Wang Y; Travis J; Gajewski B
BMC Med Res Methodol; 2022 Apr; 22(1):118. PubMed ID: 35448963
[TBL] [Abstract][Full Text] [Related]
30. Incorporating historical two-arm data in clinical trials with binary outcome: A practical approach.
Feißt M; Krisam J; Kieser M
Pharm Stat; 2020 Sep; 19(5):662-678. PubMed ID: 32227680
[TBL] [Abstract][Full Text] [Related]
31. Bayesian sample size determination using commensurate priors to leverage preexperimental data.
Zheng H; Jaki T; Wason JMS
Biometrics; 2023 Jun; 79(2):669-683. PubMed ID: 35253201
[TBL] [Abstract][Full Text] [Related]
32. BASIC: A Bayesian adaptive synthetic-control design for phase II clinical trials.
Jiang L; Thall PF; Yan F; Kopetz S; Yuan Y
Clin Trials; 2023 Oct; 20(5):486-496. PubMed ID: 37313712
[TBL] [Abstract][Full Text] [Related]
33. Borrowing historical information to improve phase I clinical trials using meta-analytic-predictive priors.
Chen X; Zhang J; Jiang Q; Yan F
J Biopharm Stat; 2022 Jan; 32(1):34-52. PubMed ID: 35594366
[TBL] [Abstract][Full Text] [Related]
34. Alternative models and randomization techniques for Bayesian response-adaptive randomization with binary outcomes.
Proper J; Connett J; Murray T
Clin Trials; 2021 Aug; 18(4):417-426. PubMed ID: 33926267
[TBL] [Abstract][Full Text] [Related]
35. Bayesian semiparametric meta-analytic-predictive prior for historical control borrowing in clinical trials.
Hupf B; Bunn V; Lin J; Dong C
Stat Med; 2021 Jun; 40(14):3385-3399. PubMed ID: 33851441
[TBL] [Abstract][Full Text] [Related]
36. A comparison of Bayesian information borrowing methods in basket trials and a novel proposal of modified exchangeability-nonexchangeability method.
Daniells L; Mozgunov P; Bedding A; Jaki T
Stat Med; 2023 Oct; 42(24):4392-4417. PubMed ID: 37614070
[TBL] [Abstract][Full Text] [Related]
37. A Bayesian group sequential design for randomized biosimilar clinical trials with adaptive information borrowing from historical data.
Zhang W; Pan Z; Yuan Y
J Biopharm Stat; 2022 May; 32(3):359-372. PubMed ID: 35679137
[TBL] [Abstract][Full Text] [Related]
38. A practical Bayesian adaptive design incorporating data from historical controls.
Psioda MA; Soukup M; Ibrahim JG
Stat Med; 2018 Nov; 37(27):4054-4070. PubMed ID: 30033617
[TBL] [Abstract][Full Text] [Related]
39. Dynamic use of historical controls in clinical trials for rare disease research: A re-evaluation of the MILES trial.
Harun N; Gupta N; McCormack FX; Macaluso M
Clin Trials; 2023 Jun; 20(3):223-234. PubMed ID: 36927115
[TBL] [Abstract][Full Text] [Related]
40. Empirical bayes approach for dynamic bayesian borrowing for clinical trials in rare diseases.
Sebastien B
J Pharmacokinet Pharmacodyn; 2023 Dec; 50(6):495-499. PubMed ID: 37148459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
